Metraipolis › archive › dc_aa20cf4d696f

Efficacy and Safety of Topical 5% Cannabidiol Plus Myrcene for the Treatment of Vestibulodynia: A Multi-Centric Randomized Controlled Trial — Europe PMC PMID:41153723

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41153723
DOI
10.3390/biomedicines13102440
License (as archived)
solo-consultazione
Archived
2026-11-09T13:08:43.973Z
SHA-256 of the archived text
6fbb8241b25a1c1da854953756ea0569d4b5668bd21b557a658159f8d003da03
Stable URL of this page
https://metraipolis.com/documento/dc_aa20cf4d696f

How to cite

Efficacy and Safety of Topical 5% Cannabidiol Plus Myrcene for the Treatment of Vestibulodynia: A Multi-Centric Randomized Controlled Trial — Europe PMC PMID:41153723 — Europe PMC (en), https://europepmc.org/article/MED/41153723 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa20cf4d696f (Metraipolis archive dc_aa20cf4d696f, sha256 6fbb8241b25a1c1da854953756ea0569d4b5668bd21b557a658159f8d003da03)
BibTeX
@misc{dcaa20cf4d696f,
  title = {Efficacy and Safety of Topical 5% Cannabidiol Plus Myrcene for the Treatment of Vestibulodynia: A Multi-Centric Randomized Controlled Trial — Europe PMC PMID:41153723},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41153723},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa20cf4d696f; sha256 6fbb8241b25a1c1da854953756ea0569d4b5668bd21b557a658159f8d003da03},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41153723. Agents can read the archived copy with the MCP tool read_document.